Al-Saffar et al. reported that blockade of PI3K with LY294002 (a relatively less potent, nonselective inhibitor of PI3K) was associated with a decrease in PC levels as well as an elevation in GPC content in human breast cancer cells (Beloueche-Babari et al., 2006). This evidence concerns the gene PIK3CA and breast cancer.